A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 14 May 2018
At a glance
- Drugs Infliximab (Primary) ; Methotrexate; Methylprednisolone; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms IDEA
- 14 May 2018 Last checked against ClinicalTrials.gov record.
- 16 Sep 2016 Results of a cardiovascular substudy (n=79) published in the Rheumatology
- 29 Oct 2013 Results of the cardiovascular analysis (n=79) presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History